Cello Health PLC (LON:CLL)

Cello Health PLC (LON:CLL)


Share Price
134.00 p
Change
0 (0.00 %)
Market Cap
£140.85 m
Proactive Investors - Run By Investors For Investors

Cello Health PLC

We are a global healthcare-focused advisory group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities.

We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

We enable clients to differentiate their propositions and drive brand...

EPIC: CLL
Market: AIM:CLL
52-week High/Low: 140.07p / 95.00p
Sector: Media & Publishing
Market Cap: £140.85 m
Website: cellohealth.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Cello Health PLC


Cello Health PLC Timeline

“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use